Bone Marrow TransplantationTransplantation, AutologousBone MarrowBone Marrow CellsTransplantation, HomologousHematopoietic Stem Cell TransplantationBone and BonesGraft vs Host DiseaseTransplantation ConditioningLiver TransplantationWhole-Body IrradiationBone Marrow PurgingGraft SurvivalHematopoietic Stem CellsStem Cell TransplantationKidney TransplantationLeukemiaTransplantation ChimeraAnemia, AplasticBusulfanBone Marrow DiseasesTissue DonorsCyclophosphamideMultiple MyelomaCombined Modality TherapyTreatment OutcomeHematopoiesisBone Marrow ExaminationRecurrenceBone RemodelingHistocompatibility TestingLymphoma, Non-HodgkinTransplantation, IsogeneicBone Marrow NeoplasmsRemission InductionMelphalanHistocompatibilityHeart TransplantationTime FactorsHematologic NeoplasmsMice, Inbred C57BLImmunosuppressive AgentsLeukemia, Myeloid, AcuteAntigens, CD34Graft RejectionHematopoietic Stem Cell MobilizationColony-Forming Units AssayLung TransplantationPeripheral Blood Stem Cell TransplantationRadiation ChimeraGranulocyte Colony-Stimulating FactorCarmustineTransplantation ImmunologyAntineoplastic Combined Chemotherapy ProtocolsSurvival AnalysisCell TransplantationBone DensityRetrospective StudiesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCell DifferentiationMyelodysplastic SyndromesImmunosuppressionOrgan TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaDisease-Free SurvivalCells, CulturedSalvage TherapyCytarabineBone ResorptionEtoposideSurvival RateLeukemia, MyeloidT-LymphocytesFollow-Up StudiesGraft vs Tumor EffectHodgkin DiseaseHepatic Veno-Occlusive DiseaseAcute DiseaseFlow CytometryLymphocyte DepletionGraft vs Host ReactionChimeraLymphomaHLA AntigensLeukocyte TransfusionCell SeparationCyclosporineBone NeoplasmsPrognosisSevere Combined ImmunodeficiencyPancreas TransplantationIslets of Langerhans TransplantationHematologic DiseasesSpleenTransplantationStem CellsPancytopeniaActuarial AnalysisLymphocyte TransfusionLeukapheresis